BRAF- and EGFR-driven lung cancers have been modeled in mice using a Cre/lox-regulated conditionally activatable allele of BRAF V600E (BrafCA-V600E)35 and a doxycycline regulated EGFRL858R transgene36,37. The gene discussed is BRAF; the disease is lung carcinoma.